Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
36.03
-0.98 (-2.66%)
Sep 14, 2026, 2:01 PM EDT - Market open
Nanobiotix Employees
Nanobiotix had 100 employees as of December 31, 2025. The number of employees decreased by 8 or -7.41% compared to the previous year.
Employees
100
Change (1Y)
-8
Growth (1Y)
-7.41%
Revenue / Employee
$382,682
Profits / Employee
-$281,331
Market Cap
1.85B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 100 | -8 | -7.41% | 100 | 0 |
| Dec 31, 2024 | 108 | 6 | 5.88% | 108 | 0 |
| Dec 31, 2023 | 102 | 0 | - | 102 | 0 |
| Dec 31, 2022 | 102 | 2 | 2.00% | 102 | 0 |
| Dec 31, 2021 | 100 | 10 | 11.11% | 100 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vericel | 398 |
| Vir Biotechnology | 367 |
| Biohaven | 274 |
| Xencor | 260 |
| Zymeworks | 231 |
| Lakefront Biotherapeutics NV | 196 |
| Stoke Therapeutics | 170 |
| Septerna | 123 |
NBTX News
- 8 hours ago - Nanobiotix announces updated safety, efficacy data from JNJ-1900 study - TheFly
- 12 hours ago - NANOBIOTIX Announces Complete Full Cohort Phase 1 Results for JNJ-1900 (NBTXR3) in Inoperable, Recurrent Non-Small Cell Lung Cancer - GlobeNewsWire
- 4 days ago - NANOBIOTIX to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 19 days ago - Voting Rights and Shares Capital of the Company - GlobeNewsWire
- 6 weeks ago - Voting Rights and Shares Capital of the Company - GlobeNewsWire
- 3 months ago - Voting Rights and Shares Capital of the Company - GlobeNewsWire
- 3 months ago - Nanobiotix Reports Q1 2026 Update; Expects Cash Runway Through 2029 - Nasdaq
- 3 months ago - Nanobiotix Provides First Quarter 2026 Operational and Financial Update - GlobeNewsWire